Clinical Trials Directory

Trials / Completed

CompletedNCT02252068

Study of Treatment for Opioid Dependence and Anxiety Disorders

Behavioral Treatment Development for Co-occurring Opioid Dependence and Anxiety Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Mclean Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anxiety is highly prevalent among individuals with opioid dependence and confers greater risk for continued opioid use and poor treatment outcomes. However, there are currently no efficacious treatments available for co-occurring opioid dependence and anxiety. The ultimate aims of this trial are the development and testing of a novel integrated cognitive behavioral treatment (I-CBT) for co-occurring opioid dependence and anxiety disorders. This clinical trial consists of two phases: (1) open-trial pilot (2) randomized control trial. We hypothesize that I-CBT will be a feasible and acceptable treatment that will result in significant reductions in anxiety and opioid use.

Detailed description

This Stage 1 behavioral treatment development trial involves two stages: manual development and pilot testing in an open trial, and a small randomized controlled trial. In both phases, opioid use and anxiety symptoms will be measured as the primary clinical outcome, along with measures of feasibility and patient satisfaction. These results will be used to further refine the treatment manual and to evaluate whether this treatment may enhance outcomes for adults with co-occurring opioid dependence and anxiety disorders.

Conditions

Interventions

TypeNameDescription
BEHAVIORALI-CBTNew cognitive behavioral therapy treatment manual developed to treat co-occurring anxiety and opioid dependency disorders.
BEHAVIORALIDCIndividual Drug Counseling manual that has demonstrated efficacy for the treatment of drug dependence.

Timeline

Start date
2015-01-01
Primary completion
2019-10-24
Completion
2019-12-19
First posted
2014-09-29
Last updated
2020-11-17
Results posted
2020-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02252068. Inclusion in this directory is not an endorsement.